Results. The Parties mutually acknowledge right now that, in the course of the implementation of the project, each one will and/or may share their own know-how and/or assets covered by industrial and/or intellectual property rights (“Background”). Nothing in this agreement shall affect the ownership of Background or of intellectual property rights generated outside the action which one Party agrees to make available to the other Party in the course of the action. If one Party makes its Background available to the other Party in the course of the Action, the Party receiving such Background shall treat it as Confidential Information and shall not disclose it to a third party nor use it for any purposes other than that for which it was made available to that Party. Each Party hereby agrees to make any Background which is relevant to the action available to the other Party solely for the purposes of undertaking the action Results are owned by the Party that generates them. Each Party may protect the Results at its own expense in such manner as it deems appropriate (e.g., filing patent applications, in any state it deems appropriate, with respect to any patentable invention covered by such Results), subject to the provisions of this agreement. Prior notice of any planned patent filing shall be given to the other Party at least 45 calendar days before the filing. All Results, created by the Principal Investigator during the Secondment Period(s) and/or where the Parties respective contribution in generating such Results cannot be ascertained, shall be joint owned by the Parties. In cases of innovative Results, susceptible to patent (or similar) protection and/or economic exploitation, the joint-ownership Parties undertake to regulate in a specific agreement the procedures for the protection and exploitation of such Results; in this case, any publications will be subject to the completion of all procedures suitable for the patent protection of the Results. Any use for internal research and educational purposes shall be on a royalty-free basis. No joint-owner shall assign its ownership interest in the joint Results to any third party without the prior written consent of the other joint ownership Party.
Results. Paper copies of the results will not be distributed and will be available live at the following links: • Official Virtual Notice Board • ACI Sport
Results. Seventeen Universities across Italy participated in the study; 58.2% had compulsory tuberculin skin test (TST) either at enrollment or to attend clinical practice. A total of 5,209 students responded to the questionnaire. Overall, 37.7% were medicine and dentistry students (Group1), 44.9% were nursing students (Group 2) and 17.4% were other health professions’ students (Group 3). Age and gender were differentially distributed by groups, as well as knowledge and practice on TST. 84.4% of the study population (95% CI = 83.3-85.3) was aware of the existence of the TST, 74.4% (95% CI = 73.2-75.6) knew what is the first-level screening test for latent tuberculosis and only 22.5% (95% CI = 21.4-23.6) knew how to proceed after a positive TST result. Overall, knowledge on TB prevention was higher in Group 2 and lower Group 3, as compared to Group 1.
Results. According to selected studies (n=19), an association between consumption of SEIM and several behavioural, psychophysical and social outcomes is confirmed. Using SEIM induces sexual uncertainty and instrumental attitudes toward sex, considered as primarily physical and casual rather than affectionate and relational. This appears to be directly related to early sexual debut and positive attitudes toward casual sex. About 30-50% of adolescents using SEIM on a daily basis are more likely to experiment what they have seen. The wish to imitate depicted scripts may lead them to engage in potentially risky behaviours and especially unprotected sex, which is linked to a higher prevalence of undesired pregnancy and sexually transmitted diseases. Use of SEIM is also associated with sexting, as it doubles the chance of sending or receiving sexually explicit material.
Results. According to selected studies (n=24), the prevalence of boys approaching SEIM ranges between 56% and 100%, whereas the percentage widely varies between 7.6% and 82% for girls. The first exposure to SEIM happens in a purely accidental way in over half of cases and at a mean age of 12 years for males and
Results. Starting from the BoC nominal state, the variation of the effective multiplication factor (keff) was evaluated in the “Pert-half” and “Pert” perturbed core conditions (§3). Table 4.1 reports the corresponding Δkeff results expressed in per cent mille (pcm), together with the Δkeff value obtained with all the 12 CRs completely withdrawn (as at EoC). These values were calculated with the fuel at BoL (§3): the complete extraction of one CR causes a +222 pcm Δkeff.
Results. 4.1 eIF6 and Malignant Pleural Mesothelioma Patients Age(years) Therapy Survival(months) Histotype Number/Sex RT: Radiotherapy Figure 13. High co-expression of eIF6 and PKCβ is associated to lower survival of MPM patients. We used data of PRKCB and eIF6 expression derived bu mesothelioma datasets to evaluate survival of MPM patients. High eIF6/high PKCβ expression correlates with lower survival.
Results. Simulations Experiments
Results. 4.1 Morphological of mitochondria isolated from post mortem human brain cortex by using Xxxx and Xxxxxxxx protocol In order to evaluate the yield of Xxxx and Xxxxxxxx method [180], mitochondria have been isolated following the same steps starting from post mortem brain tissue. The mitochondrial fraction was evaluated through transmission electron microscopy to get a rough view of their morphology and to estimate the possible contaminations. In figure 11 it is evident that the isolated human post mortem brain mitochondria are predominantly enclosed into synaptosomes together with many other cell components. Considering this result, which is far from the desired purity of mitochondria required for our purpose, the main effort of the study was to develop a new method to obtain a highly purified mitochondrial fraction from human post mortem tissues. Figure 11: Representative electron micrograph showing a mitochondrial pellet to display the characteristic morphology
Results. The literature's review has shown the Xxxxxxx’x protocol has the greatest number of sample and the best efficacy and safety data. The retrospective analysis allowed the evaluation of the group composed of 30 patients aged > 18 years, admitted to the center between January 2020 and April 2022, diagnosed with coronary artery syndrome. Figure 3. Percentage of patients with ASA allergy Figure 4. N° patients with previous manifestations of ASA allergy Figure 5. Patients assuming antiplatelet at discharge Figure 6. Patients trated with ASA at FU The evidence suggests that the Xxxxxxx’x protocol is effective for a wide spectrum of patients. The hospital pharmacist in agreement with the cardiologist will evaluate the possibility to implement a solution-based formulation to treat more fragile patients, who present history of allergy to ASA, dysphagia or requiring interventional procedures.